UPC APP 18039/2025

—·EP2279254 +1 more: NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

Case details: Status
—
Action
Procedural application
Category
Other Procedural
Parties: Claimants
Arbutus Biopharma Corporation
Genevant Sciences GmbH
Reps: Markus van Gardingen
Respondents
Moderna Belgium S.R.L.
Moderna Denmark ApS
Moderna Portugal Unipessoal LDA
Moderna Poland SP. Z.O.O.
Moderna Netherlands B.V.
Moderna Biotech UK Limited
Moderna Italy S.R.L.
Moderna France SASU
Moderna Biotech Spain SL
Moderna Germany GmbH
Moderna Sweden AB
Moderna Norway AS
ModernaTX, Inc.
Moderna, Inc.
Moderna Switzerland GmbH
Reps: Ruben Laddé; Joachim Renken
Division: The Hague LD
Judges: —
Technology: Biotechnology
Language: —
First decided: Apr 17, 2025

Decisions

2025-04-17
Generic application
The Hague Local Division issued a procedural order rejecting Moderna defendants' requests to extend the deadline for filing preliminary objections and the Statement of Defence under R. 333 RoP, while setting a single consolidated deadline for all Moderna group defendants to file one joint Statement of Defence in the Arbutus/Genevant v. Moderna infringement proceedings (UPC_CFI_191-192/2025).
Legal issues:Deadline for filing preliminary objections and Statement of DefenceStreamlining procedure for corporate group defendants (R. 333 RoP)Service of process on multiple international defendantsExpeditious proceedings in pharmaceutical infringement

Documents